Cigna earnings beat by $0.04, revenue topped estimates
Coca-Cola (NYSE:KO) Europacific Partners (NASDAQ:CCEP) reported a series of share repurchases on US trading venues and London trading venues as part of its ongoing buyback program. The company, currently trading at $20.99, near its 52-week low of $19.83, executed purchases on June 17, 18, 19, 20, and 23, 2025. According to InvestingPro analysis, CCEP maintains a "FAIR" overall financial health score of 2.43 out of 5, with particularly strong relative value metrics.
On June 17, the company bought 35,152 ordinary shares on US trading venues and 16,293 ordinary shares on London trading venues. The highest price paid per share was $93.12 on US venues and £68.70 on the London Stock Exchange (LON:LSEG), with a volume-weighted average price of $92.52 and £68.36, respectively. All repurchased shares are to be cancelled.
On June 18, Coca-Cola Europacific Partners acquired 34,953 ordinary shares on US trading venues and 16,410 ordinary shares on London trading venues. The highest price paid reached $93.50 per share in the US and £69.50 in London, with a volume-weighted average price of $93.04 and £69.09, respectively.
On June 19, no purchases were made on US trading venues due to the Juneteenth public holiday. The company bought 16,064 ordinary shares on London trading venues at prices ranging from £68.40 to £69.30 per share.
On June 20, the company purchased 34,960 ordinary shares on US trading venues and 5,358 shares on London trading venues. The highest price paid was $94.58 per share in the US and £69.10 in London. The volume-weighted average price was $93.02 and £69.00, respectively.
On June 23, Coca-Cola Europacific Partners acquired 34,995 ordinary shares on US trading venues. No shares were purchased on London trading venues that day. The highest price paid was $93.66, with a volume-weighted average price of $92.93 per share.
These transactions are part of a share buyback program announced on February 14, 2025, with an aggregate repurchase target of up to €1 billion in ordinary shares. The company, which offers a dividend yield of 3.82% and has generated revenue growth of 6.78% over the last twelve months, is listed on Euronext (EPA:ENX) Amsterdam, NASDAQ, London Stock Exchange, and Spanish Stock Exchanges under the symbol CCEP. InvestingPro subscribers can access over 30 additional financial metrics and exclusive insights about CCEP’s valuation and growth prospects. All information is based on the company’s press release statement included in the SEC filing.
In other recent news, Coca-Cola Europacific Partners has been actively engaging in a share buyback program, with transactions executed on various trading venues between June 4, 2025, and June 9, 2025. The company aims to repurchase up to EUR 1 billion of ordinary shares, and all repurchased shares are set to be canceled. Meanwhile, LATAM Airlines (NYSE:LTM) Group has entered into an underwriting agreement with J.P. Morgan Securities LLC for the sale of common shares, as part of its ongoing financial activities. The specifics regarding the size and pricing of the offering were not disclosed.
MAG Silver Corp (TSX:MAG) has announced amendments to its arrangement agreement, which could impact its operations and future strategies. The company also released related documents, indicating a significant corporate action requiring shareholder approval. Sinovac Biotech has scheduled a special shareholder meeting for July 8, 2025, with detailed agenda items to be disclosed in proxy materials. Additionally, GH Research has scheduled its annual general meeting for July 31, 2025, providing shareholders with access to proxy materials and agenda information. These developments reflect significant corporate activities and strategic decisions across various sectors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.